McGuinness et al., 2016 - Google Patents
Evasion of neutrophil killing by Staphylococcus aureusMcGuinness et al., 2016
View HTML- Document ID
- 13376677015238037374
- Author
- McGuinness W
- Kobayashi S
- DeLeo F
- Publication year
- Publication venue
- Pathogens
External Links
Snippet
Staphylococcus aureus causes many types of infections, ranging from self-resolving skin infections to severe or fatal pneumonia. Human innate immune cells, called polymorphonuclear leukocytes (PMNs or neutrophils), are essential for defense against S …
- 210000000440 Neutrophils 0 title abstract description 121
Similar Documents
Publication | Publication Date | Title |
---|---|---|
McGuinness et al. | Evasion of neutrophil killing by Staphylococcus aureus | |
Zurawski et al. | Monoclonal antibodies as an antibacterial approach against bacterial pathogens | |
Fischetti | Development of phage lysins as novel therapeutics: a historical perspective | |
Lacey et al. | The role of Staphylococcus aureus virulence factors in skin infection and their potential as vaccine antigens | |
Oliveira et al. | Staphylococcus aureus toxins and their molecular activity in infectious diseases | |
Kong et al. | Targeting Staphylococcus aureus toxins: a potential form of anti-virulence therapy | |
Ryu et al. | Colonization and infection of the skin by S. aureus: immune system evasion and the response to cationic antimicrobial peptides | |
Aman et al. | Staphylococcal bicomponent pore-forming toxins: targets for prophylaxis and immunotherapy | |
Zeng et al. | Rapid and broad immune efficacy of a recombinant five-antigen vaccine against Staphylococcus aureus infection in animal models | |
Wójcik-Bojek et al. | Staphylococcus aureus—a known opponent against host defense mechanisms and vaccine development—do we still have a chance to win? | |
Abnave et al. | Coxiella burnetii lipopolysaccharide: what do we know? | |
Takehara et al. | Cellular entry of Clostridium perfringens iota-toxin and Clostridium botulinum C2 toxin | |
Venkatasubramaniam et al. | A critical role for HlgA in Staphylococcus aureus pathogenesis revealed by a switch in the SaeRS two-component regulatory system | |
BR Da Silva et al. | Advances in fungal peptide vaccines | |
Reboud et al. | Exolysin shapes the virulence of Pseudomonas aeruginosa clonal outliers | |
Löffler et al. | Staphylococcus aureus Toxins: promoter or handicap during infection? | |
Matos et al. | Moonlighting in Rickettsiales: expanding virulence landscape | |
Darisipudi et al. | Messing with the sentinels—the interaction of Staphylococcus aureus with dendritic cells | |
Rukkawattanakul et al. | Human scFvs that counteract bioactivities of Staphylococcus aureus TSST-1 | |
Garciarena et al. | Coordinated molecular cross-talk between Staphylococcus aureus, endothelial cells and platelets in bloodstream infection | |
Chalenko et al. | Phylogenetically defined isoforms of Listeria monocytogenes invasion factor InlB differently activate intracellular signaling pathways and interact with the receptor gC1q-R | |
Rudenko et al. | A monoclonal antibody against the C-terminal domain of Bacillus cereus hemolysin II inhibits HlyII cytolytic activity | |
Fernández et al. | Gram-positive pneumonia: Possibilities offered by phage therapy | |
Berger et al. | Antimicrobial resistance and novel alternative approaches to conventional antibiotics | |
Sharma et al. | Soluble T cell receptor Vβ domains engineered for high-affinity binding to staphylococcal or streptococcal superantigens |